{"id":12729,"date":"2026-03-02T15:10:24","date_gmt":"2026-03-02T15:10:24","guid":{"rendered":"https:\/\/sescs.es\/?p=12729"},"modified":"2026-03-02T15:10:24","modified_gmt":"2026-03-02T15:10:24","slug":"methodology-note-guideline-economic-evaluation-medicines","status":"publish","type":"post","link":"https:\/\/sescs.es\/en\/methodology-note-guideline-economic-evaluation-medicines\/","title":{"rendered":"SESCS PUBLICATION: Guideline for the economic evaluation of medicines: a proposal by the Spanish National Health System&#8217;s Advisory Committee for Pharmaceutical Financing"},"content":{"rendered":"<p>Marta Trapero-Bertran, Juan Oliva, Ferr\u00e1n Catal\u00e1-L\u00f3pez, Lidia Garc\u00eda-P\u00e9rez, Llu\u00eds Seg\u00fa, Emilio Jes\u00fas Alegre-del-Rey, Ana Clop\u00e9s, F\u00e9lix Lobo, Ana Ortega, Jaume Puig-Junoy<\/p>\n<p>ABSTRACT<\/p>\n<p>In 2023, the General Directorate of Pharmacy of the Ministry of Health commissioned the Advisory Committee on the Financing of Pharmaceuticals for the National Health System (CAPF, Comit\u00e9 Asesor para la Financiaci\u00f3n de la Prestaci\u00f3n Farmac\u00e9utica del Sistema Nacional de Salud) to produce a guideline for the evaluation of the efficiency of medicines. The aim of this methodological note is to present their main points. The guideline includes 17 dimensions that an economic evaluation of medicines must encompass, the design of a reference case, and a checklist for evaluating the methodological quality and reporting. This guideline should serve as a foundational document for reforming the health technologies evaluation processes of the Ministry of Health. The guideline can also assist researchers, public health professionals, health technology companies and decision makers in assessing the validity of findings and conclusions from health economic evaluations.<\/p>\n<p>You can read the full article <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0213911125000020\" target=\"_blank\" rel=\"noopener\">here<\/a>.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Marta Trapero-Bertran, Juan Oliva, Ferr\u00e1n Catal\u00e1-L\u00f3pez, Lidia Garc\u00eda-P\u00e9rez, Llu\u00eds Seg\u00fa, Emilio Jes\u00fas Alegre-del-Rey, Ana Clop\u00e9s, F\u00e9lix Lobo, Ana Ortega, Jaume &hellip; <\/p>\n","protected":false},"author":3,"featured_media":6868,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[229,105],"tags":[302,557,558,517,556,412],"class_list":["post-12729","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-featured","category-news","tag-economic-evaluation","tag-guideline","tag-medicines","tag-national-health-system","tag-pricing-and-reimbursement","tag-spain"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SESCS PUBLICATION: Guideline for the economic evaluation of medicines: a proposal by the Spanish National Health System&#039;s Advisory Committee for Pharmaceutical Financing | SESCS<\/title>\n<meta name=\"description\" content=\"Mantente al d\u00eda de las novedades del Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de la Salud (SESCS).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sescs.es\/en\/methodology-note-guideline-economic-evaluation-medicines\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SESCS PUBLICATION: Guideline for the economic evaluation of medicines: a proposal by the Spanish National Health System&#039;s Advisory Committee for Pharmaceutical Financing | SESCS\" \/>\n<meta property=\"og:description\" content=\"Mantente al d\u00eda de las novedades del Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de la Salud (SESCS).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sescs.es\/en\/methodology-note-guideline-economic-evaluation-medicines\/\" \/>\n<meta property=\"og:site_name\" content=\"SESCS\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SESCS2018\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-02T15:10:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sescs.es\/wp-content\/uploads\/2022\/11\/Imagen-noticia-Sescs-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"956\" \/>\n\t<meta property=\"og:image:height\" content=\"507\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"DifusionSESCS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@_SESCS_\" \/>\n<meta name=\"twitter:site\" content=\"@_SESCS_\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DifusionSESCS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/sescs.es\/en\/methodology-note-guideline-economic-evaluation-medicines\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/sescs.es\/en\/methodology-note-guideline-economic-evaluation-medicines\/\"},\"author\":{\"name\":\"DifusionSESCS\",\"@id\":\"https:\/\/sescs.es\/#\/schema\/person\/0afad8715d2bf9946320c765357c64b4\"},\"headline\":\"SESCS PUBLICATION: Guideline for the economic evaluation of medicines: a proposal by the Spanish National Health System&#8217;s Advisory Committee for Pharmaceutical Financing\",\"datePublished\":\"2026-03-02T15:10:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/sescs.es\/en\/methodology-note-guideline-economic-evaluation-medicines\/\"},\"wordCount\":203,\"publisher\":{\"@id\":\"https:\/\/sescs.es\/#organization\"},\"image\":{\"@id\":\"https:\/\/sescs.es\/en\/methodology-note-guideline-economic-evaluation-medicines\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/sescs.es\/wp-content\/uploads\/2022\/11\/Imagen-noticia-Sescs-2.jpg\",\"keywords\":[\"Economic Evaluation\",\"Guideline\",\"Medicines\",\"national-health-system\",\"Pricing and reimbursement\",\"Spain\"],\"articleSection\":[\"Featured\",\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/sescs.es\/en\/methodology-note-guideline-economic-evaluation-medicines\/\",\"url\":\"https:\/\/sescs.es\/en\/methodology-note-guideline-economic-evaluation-medicines\/\",\"name\":\"SESCS PUBLICATION: Guideline for the economic evaluation of medicines: a proposal by the Spanish National Health System's Advisory Committee for Pharmaceutical Financing | SESCS\",\"isPartOf\":{\"@id\":\"https:\/\/sescs.es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/sescs.es\/en\/methodology-note-guideline-economic-evaluation-medicines\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/sescs.es\/en\/methodology-note-guideline-economic-evaluation-medicines\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/sescs.es\/wp-content\/uploads\/2022\/11\/Imagen-noticia-Sescs-2.jpg\",\"datePublished\":\"2026-03-02T15:10:24+00:00\",\"description\":\"Mantente al d\u00eda de las novedades del Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de la Salud (SESCS).\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/sescs.es\/en\/methodology-note-guideline-economic-evaluation-medicines\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/sescs.es\/en\/methodology-note-guideline-economic-evaluation-medicines\/#primaryimage\",\"url\":\"https:\/\/sescs.es\/wp-content\/uploads\/2022\/11\/Imagen-noticia-Sescs-2.jpg\",\"contentUrl\":\"https:\/\/sescs.es\/wp-content\/uploads\/2022\/11\/Imagen-noticia-Sescs-2.jpg\",\"width\":956,\"height\":507,\"caption\":\"Predictores sociodemogr\u00e1ficos y cl\u00ednicos de la adherencia a los antidepresivos en los trastornos depresivos: una revisi\u00f3n sistem\u00e1tica con un metan\u00e1lisis\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/sescs.es\/#website\",\"url\":\"https:\/\/sescs.es\/\",\"name\":\"SESCS\",\"description\":\"Servicio de Evaluaci\u00f3n del Servicio Canario de Salud - Reduciendo la incertidumbre en las decisiones\",\"publisher\":{\"@id\":\"https:\/\/sescs.es\/#organization\"},\"alternateName\":\"Servicio de Evaluaci\u00f3n del Servicio Canario de Salud\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/sescs.es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/sescs.es\/#organization\",\"name\":\"SESCS\",\"alternateName\":\"Servicio de Evaluaci\u00f3n del Servicio Canario de Salud\",\"url\":\"https:\/\/sescs.es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/sescs.es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/sescs.es\/wp-content\/uploads\/2022\/04\/Imagen-noticia-Sescs-2.png\",\"contentUrl\":\"https:\/\/sescs.es\/wp-content\/uploads\/2022\/04\/Imagen-noticia-Sescs-2.png\",\"width\":956,\"height\":507,\"caption\":\"SESCS\"},\"image\":{\"@id\":\"https:\/\/sescs.es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SESCS2018\",\"https:\/\/x.com\/_SESCS_\",\"https:\/\/www.linkedin.com\/company\/sescs-canarias\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/sescs.es\/#\/schema\/person\/0afad8715d2bf9946320c765357c64b4\",\"name\":\"DifusionSESCS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/c24f11df1d2d674dcd9fa2615e7ce27c9c510cedb6048bb0e9f2e622d2334ddc?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c24f11df1d2d674dcd9fa2615e7ce27c9c510cedb6048bb0e9f2e622d2334ddc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c24f11df1d2d674dcd9fa2615e7ce27c9c510cedb6048bb0e9f2e622d2334ddc?s=96&d=mm&r=g\",\"caption\":\"DifusionSESCS\"},\"url\":\"https:\/\/sescs.es\/en\/author\/difusionsescs\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SESCS PUBLICATION: Guideline for the economic evaluation of medicines: a proposal by the Spanish National Health System's Advisory Committee for Pharmaceutical Financing | SESCS","description":"Mantente al d\u00eda de las novedades del Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de la Salud (SESCS).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sescs.es\/en\/methodology-note-guideline-economic-evaluation-medicines\/","og_locale":"en_US","og_type":"article","og_title":"SESCS PUBLICATION: Guideline for the economic evaluation of medicines: a proposal by the Spanish National Health System's Advisory Committee for Pharmaceutical Financing | SESCS","og_description":"Mantente al d\u00eda de las novedades del Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de la Salud (SESCS).","og_url":"https:\/\/sescs.es\/en\/methodology-note-guideline-economic-evaluation-medicines\/","og_site_name":"SESCS","article_publisher":"https:\/\/www.facebook.com\/SESCS2018","article_published_time":"2026-03-02T15:10:24+00:00","og_image":[{"width":956,"height":507,"url":"https:\/\/sescs.es\/wp-content\/uploads\/2022\/11\/Imagen-noticia-Sescs-2.jpg","type":"image\/jpeg"}],"author":"DifusionSESCS","twitter_card":"summary_large_image","twitter_creator":"@_SESCS_","twitter_site":"@_SESCS_","twitter_misc":{"Written by":"DifusionSESCS","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/sescs.es\/en\/methodology-note-guideline-economic-evaluation-medicines\/#article","isPartOf":{"@id":"https:\/\/sescs.es\/en\/methodology-note-guideline-economic-evaluation-medicines\/"},"author":{"name":"DifusionSESCS","@id":"https:\/\/sescs.es\/#\/schema\/person\/0afad8715d2bf9946320c765357c64b4"},"headline":"SESCS PUBLICATION: Guideline for the economic evaluation of medicines: a proposal by the Spanish National Health System&#8217;s Advisory Committee for Pharmaceutical Financing","datePublished":"2026-03-02T15:10:24+00:00","mainEntityOfPage":{"@id":"https:\/\/sescs.es\/en\/methodology-note-guideline-economic-evaluation-medicines\/"},"wordCount":203,"publisher":{"@id":"https:\/\/sescs.es\/#organization"},"image":{"@id":"https:\/\/sescs.es\/en\/methodology-note-guideline-economic-evaluation-medicines\/#primaryimage"},"thumbnailUrl":"https:\/\/sescs.es\/wp-content\/uploads\/2022\/11\/Imagen-noticia-Sescs-2.jpg","keywords":["Economic Evaluation","Guideline","Medicines","national-health-system","Pricing and reimbursement","Spain"],"articleSection":["Featured","News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/sescs.es\/en\/methodology-note-guideline-economic-evaluation-medicines\/","url":"https:\/\/sescs.es\/en\/methodology-note-guideline-economic-evaluation-medicines\/","name":"SESCS PUBLICATION: Guideline for the economic evaluation of medicines: a proposal by the Spanish National Health System's Advisory Committee for Pharmaceutical Financing | SESCS","isPartOf":{"@id":"https:\/\/sescs.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sescs.es\/en\/methodology-note-guideline-economic-evaluation-medicines\/#primaryimage"},"image":{"@id":"https:\/\/sescs.es\/en\/methodology-note-guideline-economic-evaluation-medicines\/#primaryimage"},"thumbnailUrl":"https:\/\/sescs.es\/wp-content\/uploads\/2022\/11\/Imagen-noticia-Sescs-2.jpg","datePublished":"2026-03-02T15:10:24+00:00","description":"Mantente al d\u00eda de las novedades del Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de la Salud (SESCS).","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sescs.es\/en\/methodology-note-guideline-economic-evaluation-medicines\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/sescs.es\/en\/methodology-note-guideline-economic-evaluation-medicines\/#primaryimage","url":"https:\/\/sescs.es\/wp-content\/uploads\/2022\/11\/Imagen-noticia-Sescs-2.jpg","contentUrl":"https:\/\/sescs.es\/wp-content\/uploads\/2022\/11\/Imagen-noticia-Sescs-2.jpg","width":956,"height":507,"caption":"Predictores sociodemogr\u00e1ficos y cl\u00ednicos de la adherencia a los antidepresivos en los trastornos depresivos: una revisi\u00f3n sistem\u00e1tica con un metan\u00e1lisis"},{"@type":"WebSite","@id":"https:\/\/sescs.es\/#website","url":"https:\/\/sescs.es\/","name":"SESCS","description":"Servicio de Evaluaci\u00f3n del Servicio Canario de Salud - Reduciendo la incertidumbre en las decisiones","publisher":{"@id":"https:\/\/sescs.es\/#organization"},"alternateName":"Servicio de Evaluaci\u00f3n del Servicio Canario de Salud","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sescs.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/sescs.es\/#organization","name":"SESCS","alternateName":"Servicio de Evaluaci\u00f3n del Servicio Canario de Salud","url":"https:\/\/sescs.es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/sescs.es\/#\/schema\/logo\/image\/","url":"https:\/\/sescs.es\/wp-content\/uploads\/2022\/04\/Imagen-noticia-Sescs-2.png","contentUrl":"https:\/\/sescs.es\/wp-content\/uploads\/2022\/04\/Imagen-noticia-Sescs-2.png","width":956,"height":507,"caption":"SESCS"},"image":{"@id":"https:\/\/sescs.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SESCS2018","https:\/\/x.com\/_SESCS_","https:\/\/www.linkedin.com\/company\/sescs-canarias\/"]},{"@type":"Person","@id":"https:\/\/sescs.es\/#\/schema\/person\/0afad8715d2bf9946320c765357c64b4","name":"DifusionSESCS","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/c24f11df1d2d674dcd9fa2615e7ce27c9c510cedb6048bb0e9f2e622d2334ddc?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c24f11df1d2d674dcd9fa2615e7ce27c9c510cedb6048bb0e9f2e622d2334ddc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c24f11df1d2d674dcd9fa2615e7ce27c9c510cedb6048bb0e9f2e622d2334ddc?s=96&d=mm&r=g","caption":"DifusionSESCS"},"url":"https:\/\/sescs.es\/en\/author\/difusionsescs\/"}]}},"_links":{"self":[{"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/posts\/12729","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/comments?post=12729"}],"version-history":[{"count":1,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/posts\/12729\/revisions"}],"predecessor-version":[{"id":12730,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/posts\/12729\/revisions\/12730"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/media\/6868"}],"wp:attachment":[{"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/media?parent=12729"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/categories?post=12729"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/tags?post=12729"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}